The event is a key symposium in the field of medicinal chemistry and drug discovery and it traditionally attracts participants both from industry and academia.

Topics

• Chemical Biology
  Small Molecule Treatments for Protein Misfolding Diseases
  Tackling “Difficult-to-Drug”-Targets with Chemical Biology Approaches
  Bio-orthogonal Synthetic Chemistry
  Targeting RNA and RNA-modifying Enzymes
  Solute Carrier Protein (SLC) Transporters as Targets for Drug Discovery
  Chemical Induced Proximity Approaches for Therapeutic Intervention
  Targeting RAS

• Drug Discovery Projects
  Drug Discovery Beyond the Rule of Five
  Chemical Strategies to Modulate NeuroinflammationTrends in Peptide Drug Discovery
  Advances in Immuno-oncology Therapy with Small Molecule Inhibitors
  Impact of Cryo-EM in Drug Discovery
  Early Integration of Translational Strategies into Discovery Projects
  Addressing Unmet Needs on Emerging and Re-emerging Infectious Diseases

• Technologies

  Novel Methodologies in Photo- and Electrochemistry
  Reality Check “AI in Drug Design” – State of the Art or Fiction
  New Technologies for the Discovery of Protein Degraders
  Sustainability – Green Chemistry
  DNA-Encoded Libraries
  Biomimetic Drug Delivery Systems

• Early Career Women in Medicinal Chemistry & Chemical Biology

Selected Speakers

• Jacob BRADBURY, UNIVERSITY OF OXFORD, UK
• Véronique GOUVERNEUR, UNIVERSITY OF OXFORD, UK
• David MACMILLAN, PRINCETON UNIVERSITY, USA
• Emma PARMEE, JANSSEN RESEARCH & DEVELOPMENT, Spring House, USA